Annual Working Capital
$438.87 M
+$94.59 M+27.48%
December 31, 2023
Summary
- As of February 12, 2025, TVTX annual working capital is $438.87 million, with the most recent change of +$94.59 million (+27.48%) on December 31, 2023.
- During the last 3 years, TVTX annual working capital has risen by +$121.12 million (+38.12%).
- TVTX annual working capital is now -4.33% below its all-time high of $458.74 million, reached on December 31, 2021.
Performance
TVTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$134.70 M
-$113.01 M-45.62%
September 30, 2024
Summary
- As of February 12, 2025, TVTX quarterly working capital is $134.70 million, with the most recent change of -$113.01 million (-45.62%) on September 30, 2024.
- Over the past year, TVTX quarterly working capital has dropped by -$304.17 million (-69.31%).
- TVTX quarterly working capital is now -75.37% below its all-time high of $546.80 million, reached on September 30, 2023.
Performance
TVTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TVTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.5% | -69.3% |
| 3 y3 years | +38.1% | -60.9% |
| 5 y5 years | +12.2% | -60.9% |
TVTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.3% | +27.5% | -75.4% | at low |
| 5 y | 5-year | -4.3% | +38.1% | -75.4% | at low |
| alltime | all time | -4.3% | +725.1% | -75.4% | +225.9% |
Travere Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $134.70 M(-45.6%) |
| Jun 2024 | - | $247.71 M(-19.5%) |
| Mar 2024 | - | $307.85 M(-29.9%) |
| Dec 2023 | $438.87 M(+27.5%) | $438.87 M(-19.7%) |
| Sep 2023 | - | $546.80 M(+34.6%) |
| Jun 2023 | - | $406.34 M(-14.3%) |
| Mar 2023 | - | $474.26 M(+37.8%) |
| Dec 2022 | $344.27 M(-25.0%) | $344.27 M(-14.7%) |
| Sep 2022 | - | $403.81 M(-12.6%) |
| Jun 2022 | - | $462.29 M(-9.6%) |
| Mar 2022 | - | $511.62 M(+11.5%) |
| Dec 2021 | $458.74 M(+44.4%) | $458.74 M(-1.5%) |
| Sep 2021 | - | $465.92 M(+2.9%) |
| Jun 2021 | - | $452.82 M(-5.7%) |
| Mar 2021 | - | $480.03 M(+51.1%) |
| Dec 2020 | $317.75 M(-4.8%) | $317.75 M(-24.8%) |
| Sep 2020 | - | $422.26 M(-3.1%) |
| Jun 2020 | - | $435.63 M(+28.7%) |
| Mar 2020 | - | $338.54 M(+1.5%) |
| Dec 2019 | $333.62 M(-14.7%) | $333.62 M(-5.1%) |
| Sep 2019 | - | $351.70 M(-4.0%) |
| Jun 2019 | - | $366.43 M(-1.3%) |
| Mar 2019 | - | $371.44 M(-5.0%) |
| Dec 2018 | $391.06 M(+62.8%) | $391.06 M(-3.0%) |
| Sep 2018 | - | $403.12 M(+129.8%) |
| Jun 2018 | - | $175.42 M(-23.8%) |
| Mar 2018 | - | $230.28 M(-4.1%) |
| Dec 2017 | $240.14 M | $240.14 M(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $241.44 M(+0.6%) |
| Jun 2017 | - | $240.03 M(-2.4%) |
| Mar 2017 | - | $245.84 M(-1.3%) |
| Dec 2016 | $249.09 M(+15.9%) | $249.09 M(-2.9%) |
| Sep 2016 | - | $256.60 M(+16.6%) |
| Jun 2016 | - | $220.09 M(-4.8%) |
| Mar 2016 | - | $231.12 M(+7.5%) |
| Dec 2015 | $214.95 M(-406.2%) | $214.95 M(+8.6%) |
| Sep 2015 | - | $198.01 M(+173.7%) |
| Jun 2015 | - | $72.36 M(-44.9%) |
| Mar 2015 | - | $131.38 M(-287.1%) |
| Dec 2014 | -$70.20 M(+141.6%) | -$70.20 M(+1802.4%) |
| Sep 2014 | - | -$3.69 M(-168.2%) |
| Jun 2014 | - | $5.41 M(-105.1%) |
| Mar 2014 | - | -$107.00 M(+268.2%) |
| Dec 2013 | -$29.06 M(+404.1%) | -$29.06 M(+181.6%) |
| Sep 2013 | - | -$10.32 M(-3.8%) |
| Jun 2013 | - | -$10.73 M(-853.8%) |
| Mar 2013 | - | $1.42 M(-2295.8%) |
| Dec 2012 | -$5.77 M(+9037.7%) | - |
| Nov 2012 | - | -$64.80 K(+1.1%) |
| Aug 2012 | - | -$64.10 K(+0.8%) |
| May 2012 | - | -$63.60 K(+0.8%) |
| Feb 2012 | - | -$63.10 K(+2.1%) |
| Feb 2012 | -$63.10 K(+4.8%) | - |
| Nov 2011 | - | -$61.80 K(+70.2%) |
| Aug 2011 | - | -$36.30 K(-39.7%) |
| Feb 2011 | -$60.20 K | -$60.20 K |
FAQ
- What is Travere Therapeutics annual working capital?
- What is the all time high annual working capital for Travere Therapeutics?
- What is Travere Therapeutics annual working capital year-on-year change?
- What is Travere Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Travere Therapeutics?
- What is Travere Therapeutics quarterly working capital year-on-year change?
What is Travere Therapeutics annual working capital?
The current annual working capital of TVTX is $438.87 M
What is the all time high annual working capital for Travere Therapeutics?
Travere Therapeutics all-time high annual working capital is $458.74 M
What is Travere Therapeutics annual working capital year-on-year change?
Over the past year, TVTX annual working capital has changed by +$94.59 M (+27.48%)
What is Travere Therapeutics quarterly working capital?
The current quarterly working capital of TVTX is $134.70 M
What is the all time high quarterly working capital for Travere Therapeutics?
Travere Therapeutics all-time high quarterly working capital is $546.80 M
What is Travere Therapeutics quarterly working capital year-on-year change?
Over the past year, TVTX quarterly working capital has changed by -$304.17 M (-69.31%)